Onconetix, Inc.
ONCO
$2.76
$0.197.42%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.22M | 1.33M | 1.93M | 2.52M | 1.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.22M | 1.33M | 1.93M | 2.52M | 1.87M |
| Cost of Revenue | 178.60K | 445.20K | 1.01M | 1.47M | 2.60M |
| Gross Profit | 1.05M | 881.70K | 911.90K | 1.06M | -732.10K |
| SG&A Expenses | 5.97M | 6.27M | 6.97M | 9.03M | 15.03M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.06M | 6.74M | 8.11M | 10.66M | 17.59M |
| Operating Income | -4.84M | -5.41M | -6.19M | -8.13M | -15.72M |
| Income Before Tax | -50.06M | -45.16M | -57.04M | -59.74M | -51.74M |
| Income Tax Expenses | -918.00K | -974.40K | -923.60K | -1.05M | -139.80K |
| Earnings from Continuing Operations | -49.14 | -44.18 | -56.12 | -58.69 | -51.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.14M | -44.18M | -56.12M | -58.69M | -51.60M |
| EBIT | -4.84M | -5.41M | -6.19M | -8.13M | -15.72M |
| EBITDA | -4.70M | -5.08M | -5.66M | -7.40M | -15.07M |
| EPS Basic | -346.91 | -589.74 | -582.83 | -543.38 | -249.08 |
| Normalized Basic EPS | 0.71 | -119.21 | -117.44 | -111.98 | -120.21 |
| EPS Diluted | -346.91 | -589.74 | -582.83 | -543.38 | -249.08 |
| Normalized Diluted EPS | 0.71 | -119.21 | -117.44 | -111.98 | -120.21 |
| Average Basic Shares Outstanding | 2.28M | 892.90K | 332.70K | 116.10K | 15.40K |
| Average Diluted Shares Outstanding | 2.28M | 892.90K | 332.70K | 116.10K | 15.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |